Which peptides have been studied in mitochondrial research?
-
Elamipretide
Synthetic four-amino-acid peptide studied in rare mitochondrial diseases. US accelerated approval for Barth syndrome; not authorised in the UK. A large phase 3 trial failed.
PreliminaryNot licensed in the UK
Best recorded finding for each peptide in this area
| Peptide | UK status | Finding | Study type | Evidence grade |
|---|---|---|---|---|
| Elamipretide | Not licensed in the UK | Barth syndrome, 168-week extension | Human trial | Preliminary |
About this research area
"Mitochondrial Research" groups peptides studied for effects on mitochondrial function, including rare inherited mitochondrial diseases. Evidence in this category ranges from cell and animal work to small human trials in ultra-rare conditions and one large phase 3 trial that did not meet its endpoints. Inclusion reflects a documented line of mitochondrial research, not a demonstrated benefit.
0 sources in the library relate to this area. See them.
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.